These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26316014)

  • 1. Mathematical Modelling and Prediction of the Effect of Chemotherapy on Cancer Cells.
    Namazi H; Kulish VV; Wong A
    Sci Rep; 2015 Aug; 5():13583. PubMed ID: 26316014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical Based Calculation of Drug Penetration Depth in Solid Tumors.
    Namazi H; Kulish VV; Wong A; Nazeri S
    Biomed Res Int; 2016; 2016():8437247. PubMed ID: 27376087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
    Engel J; Emons G; Pinski J; Schally AV
    Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy.
    Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
    Cancer Lett; 2006 Jul; 239(1):84-97. PubMed ID: 16143448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.
    Popilski H; Stepensky D
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):767-84. PubMed ID: 25813659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
    Boldrini JL; Costa MI
    IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response.
    Rodrigues DS; de Arruda Mancera PF
    Math Biosci Eng; 2013 Feb; 10(1):221-34. PubMed ID: 23311370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical-based modeling and prediction of the effect of external stimuli on human gait.
    Namazi H; Kulish VV
    Int J Numer Method Biomed Eng; 2017 Mar; 33(3):. PubMed ID: 27229881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.
    Farrell NP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):1-9. PubMed ID: 15726528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cancer therapies: treatments driven by tumour biology.
    Ramaswami R; Harding V; Newsom-Davis T
    Postgrad Med J; 2013 Nov; 89(1057):652-8. PubMed ID: 24129032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modelling for the assessment of the effect of drug application delays in metronomic chemotherapy of cancer due to physiological constraints.
    Mukherjee A; Majumder D
    Biosystems; 2008 Jan; 91(1):108-16. PubMed ID: 17889991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-damage sensitizers: potential new therapeutical tools to improve chemotherapy.
    Michod D; Widmann C
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):160-71. PubMed ID: 17544289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: DNA Damage as a Strategy for Anticancer Chemotherapy.
    Bozko M; Bozko A; Scholta T; Malek NP; Bozko P
    Curr Med Chem; 2017; 24(15):1487. PubMed ID: 28728539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
    Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
    IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy.
    López AG; Seoane JM; Sanjuán MA
    Bull Math Biol; 2014 Nov; 76(11):2884-906. PubMed ID: 25348062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational experiments reveal the efficacy of targeting CDK2 and CKIs for significantly lowering cellular senescence bar for potential cancer treatment.
    Ling H; Samarasinghe S; Kulasiri D
    Biosystems; 2013 Feb; 111(2):71-82. PubMed ID: 23254306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical modeling of cancer progression and response to chemotherapy.
    Sanga S; Sinek JP; Frieboes HB; Ferrari M; Fruehauf JP; Cristini V
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1361-76. PubMed ID: 17069522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.